These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10331075)

  • 21. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
    Bai HW; Shim JY; Yu J; Zhu BT
    Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of 197 genetic variations in six human methyltranferase genes in the Japanese population.
    Saito S; Iida A; Sekine A; Miura Y; Sakamoto T; Ogawa C; Kawauchi S; Higuchi S; Nakamura Y
    J Hum Genet; 2001; 46(9):529-37. PubMed ID: 11558902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
    Serpe L; Canaparo R; Scordo MG; Spina E
    Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.
    Pillans PI
    Intern Med J; 2001 Nov; 31(8):476-8. PubMed ID: 11720061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity].
    Corominas H; Díaz C; Vázquez G; Baiget M
    Rev Esp Enferm Dig; 2002 Oct; 94(10):635-6. PubMed ID: 12647415
    [No Abstract]   [Full Text] [Related]  

  • 26. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
    Girard B; Otterness DM; Wood TC; Honchel R; Wieben ED; Weinshilboum RM
    Mol Pharmacol; 1994 Mar; 45(3):461-8. PubMed ID: 8145732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics of methyl conjugation and thiopurine drug toxicity.
    Weinshilboum R
    Bioessays; 1987 Aug; 7(2):78-82. PubMed ID: 3632658
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
    Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
    Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of enzyme and methyl donor for methylation reactions.
    Leysen J; Laduron P
    Arch Int Physiol Biochim; 1973 Dec; 81(5):978. PubMed ID: 4133556
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of phosphatidylcholine biosynthesis by the methylation pathway in rat pituitary gland.
    Prasad C; Edwards RM
    Horm Metab Res; 1984 Aug; 16(8):431-4. PubMed ID: 6469209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metoprine, an inhibitor of histamine N-methyltransferase but not catechol-O-methyltransferase, suppresses feeding in sated and in food deprived rats.
    Lecklin A; Tuomisto L; MacDonald E
    Methods Find Exp Clin Pharmacol; 1995; 17(1):47-52. PubMed ID: 7542717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.
    Szumlanski CL; Honchel R; Scott MC; Weinshilboum RM
    Pharmacogenetics; 1992 Aug; 2(4):148-59. PubMed ID: 1306116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
    Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Maw HH; Zeng X; Campbell S; Taub ME; Teitelbaum AM
    Drug Metab Dispos; 2018 Jun; 46(6):770-778. PubMed ID: 29514826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological ethnic metabolic safety. Communication II].
    Piruzian LA; Mikhaĭlovskiĭ EM
    Fiziol Cheloveka; 2004; 30(2):76-85. PubMed ID: 15150978
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural analysis of histamine N-methyltransferase gene.
    Takemura M; Yamauchi K; Yamatodani A
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():1-4. PubMed ID: 8750786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1.
    Lee D; Szumlanski C; Houtman J; Honchel R; Rojas K; Overhauser J; Wieben ED; Weinshilboum RM
    Drug Metab Dispos; 1995 Mar; 23(3):398-405. PubMed ID: 7628307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.